drugset / Trial / NCT07673419

A Clinical Study GK01 Cell Injection in Subjects With Advanced Lung Cancer

NCT07673419 ↗

Phase 0 Not yet recruiting 10 enrolled Beijing Geekgene Technology Co., LTD
NaSingle-groupOpen-labelTreatment

Summary

A Single-Arm, Open-Label Clinical Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of GK01 Cell Injection in Participants with Advanced Lung Cancer

Timeline

Start
2026-07
Primary completion
2028-06
Completion
2028-07

Drugs

EvaluationDrugModalityDoseRoute
Subject GK01 Cell therapy — —

Indications